Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 4
1(20.0%)
5Total
N/A(4)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07398118Not ApplicableNot Yet Recruiting

CRYO-1: Cryoablation in Elderly Patients With Early-Stage Breast Cancer.

Role: collaborator

NCT06875258Phase 4Recruiting

PEnile ReHABilitation After Nerve Sparing Robot-assisted Radical Prostatectomy for Prostate Cancer 2.0 (PEHAB-II)

Role: collaborator

NCT06082492Not ApplicableRecruiting

The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer Patients

Role: collaborator

NCT06762652Not ApplicableNot Yet Recruiting

ImpRovEd Care After eSophageCtomy Using an Algorithm for postoperativE Complications - RESCUE Trial

Role: collaborator

NCT06636370Not ApplicableRecruiting

Supplemental Screening for Women With Extremely Dense Breast Tissue: the DENSE-2 Trial

Role: collaborator

All 5 trials loaded